Krishnan Rajesh

Chief Technical OfficerOncternal Therapeutics, Inc. (ONCT) · full profile →Form 4 · filed Oct 4, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
14
0 non-derivative · 14 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 2, 2023Grant(A)75K75K
Oct 2, 2023Grant(A)40K40K
Oct 2, 2023Grant(A)12K12K
Oct 2, 2023Grant(A)160K160K
Oct 2, 2023Grant(A)177K177K
Oct 2, 2023Grant(A)29K29K
Oct 2, 2023Grant(A)220K220K
Oct 2, 2023Disposed to issuer(D)75K0
Oct 2, 2023Disposed to issuer(D)40K0
Oct 2, 2023Disposed to issuer(D)12K0
Oct 2, 2023Disposed to issuer(D)160K0
Oct 2, 2023Disposed to issuer(D)177K0
Oct 2, 2023Disposed to issuer(D)29K0
Oct 2, 2023Disposed to issuer(D)220K0

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-052014) within minutes of acceptance. Every field above traces to the original document. Verify it directly: